EU GMP Annex 1

What is an Annex 1 contamination control strategy, and how do you build one?

A contamination control strategy (CCS) is the documented, facility-wide plan that EU GMP Annex 1 requires every sterile manufacturer to hold. Here is what it must cover, and how to build and maintain one.

Short answer: A contamination control strategy is a single, documented strategy that maps every source of contamination in a sterile manufacturing facility and shows how each one is controlled. EU GMP Annex 1, in force since August 2023, makes it mandatory. It is not a single document you write once. It connects facility design, utilities, equipment, process, and monitoring into one live picture, backed by quality risk management, and it is reviewed as the site changes.

What is a contamination control strategy under Annex 1?

A CCS is a holistic, documented strategy that identifies every point where microbial, endotoxin and pyrogen, or particulate contamination could reach the product, and defines the controls that manage each one. Annex 1 asks manufacturers to look at the whole facility as one system, define the critical control points, judge how effective the controls are together, and act where the strategy is weak.

Is a contamination control strategy mandatory?

Yes. The revised EU GMP Annex 1 came into force in August 2023 and requires a formal, documented CCS for sterile and aseptic manufacturing. Inspectors now expect to see it, expect it to be specific to your site, and expect evidence that it is kept current.

What should a contamination control strategy cover?

Annex 1 points to the full contamination picture, not one part of it. A complete CCS typically addresses:

  • Facility and equipment design, including RABS and isolators
  • Clean utilities such as water systems, clean steam, and process gases
  • HVAC, cleanroom classification, and pressure regimes
  • Personnel, gowning, and aseptic behavior
  • Environmental and process monitoring, including trending
  • Cleaning, disinfection, and bio-decontamination, including H2O2 cycles
  • Raw materials, components, and container and closure integrity
  • Process design and aseptic process simulation
  • Preventive maintenance and change control

The strategy then judges how these controls perform together, so a gap in one area is visible against the whole.

How is a CCS different from having the usual procedures in place?

Standard operating procedures control single activities. A CCS sits above them and connects them, so you can show that the sum of your controls actually protects the product. It is built on quality risk management, which means each control is tied to a real, assessed risk rather than to habit or history.

How do you build and maintain a contamination control strategy?

Most sites start with a structured gap assessment against Annex 1, map the current controls, and identify where evidence or coverage is thin. From there the strategy is documented, the weak points are closed, and the CCS is placed under change control so it updates when the facility, process, or product changes. The work is ongoing: a CCS that is written once and shelved is exactly what inspectors flag.

Can a consultant help build your contamination control strategy?

Yes, and it is common. The value is in engineers who are fluent in Annex 1 and who have built and qualified real sterile facilities, not only read the guidance. Damgaard Solutions provides named senior engineers who work inside your team, from gap assessment through qualification, across the areas a CCS depends on: aseptic isolator filling, clean utilities, environmental monitoring, and CIP and SIP. Our engineers have delivered on GMP sites across Scandinavia.

What makes Damgaard Solutions' approach different?

You engage specific engineers by name before anyone sets foot in your facility, with no CV pools and no intake delays. Work is priced per signed milestone, not per hour, so the scope and the cost are clear from the start. We are part of Damgaard Group and based in Birkerød, near Copenhagen, working with GMP manufacturers across Europe.

Talk to an Annex 1 engineer

Tell us where your contamination control strategy stands and we will show you where the gaps are. Get in touch through the Damgaard Solutions contact page to start a conversation.

Related reading

Aseptic process simulation (media fill) under Annex 1

Aseptic process qualification specialists in Europe

Aseptic isolator filling

Clean utilities

Environmental monitoring

CIP and SIP

When your project can't wait. Specialist engineers, embedded from day one.

References

  1. EU GMP Annex 1, Manufacture of Sterile Medicinal Products (European Commission, EudraLex Volume 4, 2022). Published 25 August 2022, in force 25 August 2023. The source of the contamination control strategy requirement.
  2. NSF, What You Need to Know About the Annex 1 Revision. Confirms the dates and that the CCS is the most significant new requirement. nsf.org
  3. ECA Academy, What is meant by a Contamination Control Strategy (CCS) as defined in Annex 1? gmp-compliance.org
  4. PDA, EU GMP Annex 1: Implementation of Contamination Control Strategy. pda.org
  5. ICH Q9(R1), Quality Risk Management. The QRM basis a contamination control strategy is built on.

Sources retrieved September 2026. General guidance, not regulatory advice.